Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
Condition(s):Bullous PemphigoidLast Updated:February 8, 2024Withdrawn
Hide Studies Not Open or Pending
Condition(s):Bullous PemphigoidLast Updated:February 8, 2024Withdrawn
Condition(s):Thrombotic MicroangiopathiesLast Updated:February 8, 2024Recruiting
Condition(s):Atopic Keratoconjunctivitis (AKC)Last Updated:March 18, 2021Terminated
Condition(s):Bullous Pemphigoid (BP)Last Updated:June 28, 2021Completed
Condition(s):Paroxysmal Nocturnal HemoglobinuriaLast Updated:June 28, 2021Terminated
Condition(s):Paroxysmal Nocturnal Hemoglobinuria (PNH)Last Updated:November 4, 2020Completed
Condition(s):Paroxysmal Nocturnal Hemoglobinuria (PNH)Last Updated:February 8, 2024Enrolling by invitation
Condition(s):Paroxysmal Nocturnal Haemoglobinuria (PNH)Last Updated:July 12, 2023Completed
Condition(s):Atopic DermatitisLast Updated:May 6, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.